SEC Form 4 · accession 0001179110-18-005480

Teladoc Health, Inc. · TDOC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Executive VP, COO and CFO

Period of report

Apr 6, 2018

Accepted (ET)

Apr 6, 2018 · 4:03 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001477449

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Apr 6, 2018	M	10,000	$12.21	A	13,753	D
Common Stock	Apr 6, 2018	M	683	$6.01	A	14,436	D
Common Stock	Apr 6, 2018	M	2,285	$6.01	A	16,721	D
Common Stock	Apr 6, 2018	M	1,002	$1.67	A	17,723	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F1	$12.21	Apr 6, 2018	M	10,000	D	—	Mar 7, 2026	Common Stock	10,000	137,900	D
Employee Stock Option (right to buy)^F2	$6.01	Apr 6, 2018	M	2,285	D	—	Dec 22, 2024	Common Stock	2,285	47,964	D
Employee Stock Option (right to buy)^F3	$6.01	Apr 6, 2018	M	683	D	—	Sep 10, 2024	Common Stock	683	12,303	D
Employee Stock Option (right to buy)^F4	$1.67	Apr 6, 2018	M	1,002	D	—	Dec 11, 2023	Common Stock	1,002	15,020	D

F1The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter.
F2The option vests as to 25% of the shares on December 22, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter.
F3The option vests as to 25% of the shares on September 10, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter.
F4The option vests as to 25% of the shares on December 11, 2014. The remainder of the shares vest in 36 equal monthly installments thereafter.